A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case –Control Study

ConclusionsThe simple risk-scoring model may predict severe CIP in lung cancer patients receiving ICIs. For patients with high scores, clinicians should use ICIs with caution or strengthen the monitoring of these patients.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research